Physician profile
Daniel E Dosoretz
NPI 1629073200
$7,153.32
in general payments reported to CMS, 2019-2025
18 companies · $449 in 2025
The $449 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $321 · 2020: $234 · 2021: $285 · 2022: $4,486 · 2023: $898 · 2024: $480 · 2025: $449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,113 · Food and Beverage: $714.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,113.00 |
| Food and Beverage | $714.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $5,494.15 | 2021-2024 | Varian Identify, Halcyon |
| Bioprotect Medical, INC. | $267.68 | 2025 | Bioprotect Balloon Implant System |
| Boston Scientific Corporation | $260.51 | 2019-2024 | Spaceoar Vue System - 10ml |
| Varian Medical Systems, INC. | $180.69 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $147.45 | 2025 | Imfinzi |
| Novocure INC. | $134.88 | 2019-2024 | Optune |
| Blue Earth Diagnostics | $124.90 | 2019-2021 | |
| Pfizer INC. | $119.37 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $78.81 | 2019-2022 | |
| Janssen Biotech, INC. | $68.85 | 2020-2022 | |
| Dendreon Pharmaceuticals LLC | $65.99 | 2021-2025 | Provenge |
| Gt Medical Technologies, INC | $51.11 | 2022 | |
| Astellas Pharma US INC | $46.89 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $38.92 | 2020-2021 | |
| Tolmar Pharmaceuticals, INC. | $23.41 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zap Surgical Systems, INC. | $19.20 | 2020 | |
| Sumitomo Pharma America, INC. | $17.53 | 2023 | Orgovyx |
| Abbvie INC. | $12.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Dosoretz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.